Publications by authors named "Asad Mehdi"
Article Synopsis
- Mitral Regurgitation (MR) is a leading type of severe valve disease in developed nations and usually requires surgical correction, like valve replacement or repair.
- Transcatheter Mitral Valve Replacement (TMVR) is gaining traction, particularly for patients with high surgical risks, with three main types targeting specific issues like severe MR and failed surgeries.
- Recent developments, such as the FDA-approved Mitral valve-in-valve procedure and clinical trials like AHEAD, aim to improve TMVR techniques, with promising early results showing high success rates in reducing MR.
Background: Third wave of COVID-19 has affected several countries. Case fatality rates from first and second waves are expected to be surpassed by the current wave due to various variant transmissions. This study was aimed to compare and contrast the significant clinical markers between survivors and non-survivors during the third wave of COVID-19 to assess severity and prognosis.
View Article and Find Full Text PDF